Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)

This study has been terminated.
(Lack of financial support)
Sponsor:
Information provided by (Responsible Party):
Kevin Bliden, LifeBridge Health
ClinicalTrials.gov Identifier:
NCT01177592
First received: August 6, 2010
Last updated: March 18, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)